ZAP Surgical Announces Chairman of Foxconn Technology Joins Board of Directors
SAN CARLOS, Calif.–(BUSINESS WIRE)–ZAP Surgical Systems, Inc., developer and manufacturer of the ZAP-X® surgical robot for non-invasive ablation of brain tumors, today announced that the Chairman of Foxconn Technology Co Ltd, Lu Jun-Fu (Stanley Lu), has joined the ZAP Surgical Board of Directors.
“I am thrilled to welcome Stanley Lu to our Board of Directors where he will join us in our common quest to treat and transform the lives of millions of patients each year by means of the ZAP-X surgical robot,” said Dr. John R. Adler, MD, Stanford Professor of Neurosurgery and founder & Chief Executive Officer of ZAP Surgical Systems. “At ZAP we have developed the next-generation platform for non-invasively treating brain cancer. Unfortunately, more than 4 million people each year suffer from brain, head & neck cancers and are not being treated optimally with existing radiosurgical solutions. ZAP’s singular goal is to meet this challenge.”
Stanley Lu is the Chairman of Foxconn Technology Co Ltd, elected in October 2021. Stanley received an EMBA from the Chinese University of Hong Kong and an EMBA from the National Sun Yat-sen University. Prior, Stanley was the Chief Financial Officer and spokesperson of Foxsemicon Integrated Technology Inc.
Terry Guo, founder and former Chairman and Chief Executive Officer of Foxconn, co-founded ZAP Surgical in 2014, and contributed entrepreneurial expertise and his anchor investment established ZAP Surgical as an independent company. Prior to the company’s inception, the ZAP-X platform was developed within and spun out from Varian Medical Systems, now a Siemens Healthineers company.
In addition to Foxconn and Siemens Healthineers, ZAP investors include Primavera Capital Group, Chow Tai Fook Enterprises, GT Healthcare Capital Partners, ShangBay Capital, and Hogy Medical.
About ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Dr. Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at www.zapsurgical.com, or follow us on LinkedIn (https://www.linkedin.com/company/zapsurgical/) and Twitter (https://twitter.com/ZapSurgical).
The content is by Business Wire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.